Pursuant to clause 34 of the Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that it has submitted the soft copy of AGM Notice & Annual Report for year ended 31st March, 2019 of the Company.
The above information is a part of company’s filings submitted to BSE.